Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01

  • Etude concernée: IFCT-0001
  • Auteurs / Authors: Pujol JL, Breton JL, Gervais R, Tanguy ML, Quoix E, David P, Janicot H, Westeel V, Gameroff S, Geneve J, Maraninchi D
  • Journal / Conference: Journal of Clinical Oncology
  • Année / Year: 2007
  • PMID: 17761978
  • Lien vers la publication: https://www.ncbi.nlm.nih.gov/pubmed/17761978